VCY-23623-94305
3 vaccinations
6 coded responses
32 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 201 / VA
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Dose 1 — Pfizer-BioNTech
-
2021-01-17
Registered in v-safe
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
-
2021-02-06
Dose 2 — Pfizer-BioNTech
- 2021-02-06
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: GoodFree text: Lack of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-20
- 2021-03-01
- 2021-03-06
- 2021-03-13
- 2021-03-20
-
2022-01-30
Dose 3 — Pfizer-BioNTech
-
2022-01-31
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-02-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-02-03
- 2022-02-04
- 2022-02-05
- 2022-02-06
- 2022-02-13
-
2022-02-20
Survey response — day 21, dose 3MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend schoolFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
- 2022-02-27
-
2022-03-06
Survey response — day 35, dose 3MedDRA: Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: AllergiesMedDRA releases: 2024-11 · check-in free text available
-
2022-03-13
Survey response — day 42, dose 3MedDRA: Pre-existing disease — Feeling: FairFree text: AllergiesMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Survey response — 3 months, dose 3MedDRA: Migraine — Feeling: FairFree text: Migraines lasting 3 daysMedDRA releases: 2024-11 · check-in free text available
-
2022-08-02
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-06 | Pfizer-BioNTech | |
| 3 | 2022-01-30 | Pfizer-BioNTech | No |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Lack of appetite
Release 11 — day 21, dose 3
Symptoms: Miscarriage
Release 11 — day 35, dose 3
Symptoms: Allergies
Release 11 — day 42, dose 3
Symptoms: Allergies
Release 11 — 3 months, dose 3
Symptoms: Migraines lasting 3 days
Release 12 — 6 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release